From then to now
The K+S share continues to be listed on the regulated market of the German stock exchanges in Frankfurt, Hamburg, Hanover, and Stuttgart.
In addition to being listed on European stock exchanges, the K+S share is traded on the OTC market (Over The Counter, OTC) in the United States in the form of a sponsored ADR program.
You can find the baseline data and additional general information here.
| Share type | No-par value shares |
|---|---|
| Number of shares issued | 191,400,000 shares |
| Securities identification number | KSAG88 |
| ISIN | DE000KSAG888 |
| Listing | all stock exchanges in Germany |
| Ticker symbol Bloomberg | SDF GR or SDF GY |
| Ticker symbol Reuters | SDFG |
| Product code for stock option EUREX | SDXF |
| Product code for stock option Bloomberg | SDF GR Equity CT |
| Product code for stock option Reuters | 0#SDFG.DE*.EX |
| Accounting standard | IFRS |
| Market segment | Prime standard |
| Prime sector | Chemical industry |
| Industrial group | Chemicals, Commodities |
| Paying agent | Commerzbank |
We would like to point out that the search for K+S share prices in relevant financial portals or mobile phone applications (e.g. iPhone) may lead to difficulties with the "+" sign. This can easily be avoided by using our stock exchange abbreviation "SDF". We will be happy to help you with any questions you may have.
Our buy-back program
On January 19, 2017, the Board of Executive Directors of K+S Aktiengesellschaft, ISIN DE 000KSAG888, resolved to acquire up to 250,000 own shares up to a maximum total amount (excluding incidental expenses) of €6 million in April 2017 under the following conditions:
The acquired shares are to be offered for purchase to employees of K+S Aktiengesellschaft or its affiliated companies.
The buy-back will take place in accordance with section 71 (1) no. 2 of the AktG, Regulation (EC) No. 596/2014 of the European Parliament and of the Council of April 16, 2014 and Commission Regulation (EC) 2016/1052 of March 8, 2016.
The shares will be acquired via the stock exchange in Xetra trading of Deutsche Börse AG.
The buy-back will be carried out under the management of a credit institution that will make its decisions on the timing and amount of the individual order placements independently of and uninfluenced by K+S Aktiengesellschaft.
The announcement of the transactions carried out pursuant to Article 2 paragraph 3 of Commission Regulation (EC) No. 2016/1052 of March 8, 2016 will be made in the "Börsenzeitung" and with detailed information on the homepage of the Company www.k-plus-s.com under "Investor Relations".
Kassel, April 7, 2017
K+S Aktiengesellschaft
The Board of Executive Directors
Acquired shares
No-par value bearer shares of K+S Aktiengesellschaft.
Stock exchange: Xetra
| Day in 2017 | Number of shares acquired |
Ø price per share in € | Total value in € | |
|---|---|---|---|---|
| April 10 | 58,000 | 21.96 | 1,273,748.65 | Details |
| April 11 | 56,000 | 22.41 | 1,254,984.05 | Details |
| Total | 114,000 | 22.18 | 2,528,732.70 |
Historical overview of changes in share capital
You can view changes in the capital share here.
Shareholder structure characterized by high free float
According to the free float definition of Deutsche Börse AG, the free float of K+S Aktiengesellschaft is 100%. The following shareholders have notified us of shareholdings above the statutory reporting thresholds:
- DWS Investment GmbH: 5.69% (announcement of December 31, 2018)
American Depositary Receipt (ADR)
The K+S ADR program offers US investors the opportunity to acquire shares in K+S. Since the ADRs are listed in US dollars and the dividends are also paid in US dollars, the structure is essentially similar to American shares. Two ADRs are each based on one K+S share. The ADRs are traded in the form of a "Level 1" ADR program on the OTC (over the counter) market
Key facts
| Ratio | 2 ADRs = 1 share |
| OTC code | KPLUY |
| CUSIP | 48265W108 |
| OTC platform | OTCQX |
The ADR program is manged by the The Bank of New York Mellon.
Current rates can be found in the Quote data section of our website. Additional information can also be found on the OTCQX website www.otcqx.com.
Questions and answers can be found in the Q&A section.
Your contact persons
